BeStock  
Stocks › AVTX

Avalo Therapeutics AVTX

US equityMarket cap rank #3479
$13.58 −$0.01 (-0.07%)
Pre-market · Oct 8, 8:20 am ET · After hours $13.58 0.00%
Open$13.43
Prev close$13.59
Day range$13.30 – $13.98
Volume719.0K
Market cap$728.30M
P/E (TTM)–
Dividend yield–

AVTX Stock News

Headlines matching Avalo Therapeutics or the AVTX ticker, most recent first.

  • Guggenheim Maintains Avalo Therapeutics(AVTX.US) With Buy Rating, Cuts Target Price to $48 NegativeMarket news · 7 Aug 2026 · Direct mention
  • A Quick Look at Today's Ratings for Avalo Therapeutics(AVTX.US), With a Forecast Between $30 to $58Market news · 7 Aug 2026 · Direct mention
  • Leerink Partners Initiates Avalo Therapeutics(AVTX.US) With Buy Rating, Announces Target Price $38Market news · 6 Jul 2026 · Direct mention
  • BofA Securities Initiates Avalo Therapeutics(AVTX.US) With Buy Rating, Announces Target Price $35Market news · 12 Jun 2026 · Direct mention
  • TD Cowen Maintains Avalo Therapeutics(AVTX.US) With Buy RatingMarket news · 11 Jun 2026 · Direct mention
  • Stifel Maintains Avalo Therapeutics(AVTX.US) With Buy Rating, Maintains Target Price $36Market news · 7 May 2026 · Direct mention
  • Guggenheim Maintains Avalo Therapeutics(AVTX.US) With Buy Rating, Maintains Target Price $50Market news · 7 May 2026 · Direct mention
  • BTIG Maintains Avalo Therapeutics(AVTX.US) With Buy Rating, Raises Target Price to $58 PositiveMarket news · 6 May 2026 · Direct mention
  • Citizens JMP Maintains Avalo Therapeutics(AVTX.US) With Buy Rating, Raises Target Price to $62 PositiveMarket news · 6 May 2026 · Direct mention
  • BTIG Maintains Avalo Therapeutics(AVTX.US) With Buy Rating, Maintains Target Price $58Market news · 6 May 2026 · Direct mention
  • A Quick Look at Today's Ratings for Avalo Therapeutics(AVTX.US), With a Forecast Between $34 to $55Market news · 15 May 2026 · Direct mention
  • A Quick Look at Today's Ratings for Avalo Therapeutics(AVTX.US), With a Forecast Between $34 to $58Market news · 14 May 2026 · Direct mention
  • Piper Sandler Maintains Avalo Therapeutics(AVTX.US) With Buy Rating, Raises Target Price to $60 PositiveMarket news · 11 May 2026 · Direct mention
  • Wolfe Research Initiates Avalo Therapeutics(AVTX.US) With Buy Rating, Announces Target Price $48Market news · 9 Apr 2026 · Direct mention
  • Citizens JMP Initiates Avalo Therapeutics(AVTX.US) With Buy Rating, Announces Target Price $52Market news · 6 Apr 2026 · Direct mention

Discussion

No comments yet — be the first to weigh in on AVTX.

Leave a comment

Scroll to Top